You are here:
NICE
NICE Guidance
Published Guidance
Bevacizumab for the first-line treatment of metastatic breast cancer
Technology appraisal guidance
Reference number:
TA147
Published:
25 June 2008
This appraisal has been updated and replaced by
NICE technology appraisal 214
.